Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-123.75M
↓ 170% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-45.81M
Historical baseline
PeriodValueYoY Change
TTM$-123.75M-43.5%
2024$-86.23M-100.1%
2023$-43.09M-22.0%
2022$-35.31M-96.2%
2021$-18.00M-141.6%
2020$-7.45M-9.3%
2019$-6.82M-